The story of Viagra offers a complex case study for stakeholders eyeing pharma. While initial sales were astounding, recent patent lapse and the arrival of alternative versions have severely impacted earnings. In https://victorzoln752426.buyoutblog.com/41073171/viagra-and-pharma-a-dangerous-investment